Cargando…
Increased Hepatic Lipogenesis Elevates Liver Cholesterol Content
Cardiovascular diseases (CVDs) are the most common cause of death in patients with nonalcoholic fatty liver disease (NAFLD) and dyslipidemia is considered at least partially responsible for the increased CVD risk in NAFLD patients. The aim of the present study is to understand how hepatic de novo li...
Autores principales: | Berger, Jean-Mathieu, Moon, Young-Ah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941001/ https://www.ncbi.nlm.nih.gov/pubmed/33658436 http://dx.doi.org/10.14348/molcells.2021.2147 |
Ejemplares similares
-
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
por: Green, Charlotte J, et al.
Publicado: (2022) -
Exendin-4 Inhibits Hepatic Lipogenesis by Increasing β-Catenin Signaling
por: Seo, Mi Hae, et al.
Publicado: (2016) -
Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis
por: Hackl, Martina Theresa, et al.
Publicado: (2019) -
Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome
por: Knebel, Birgit, et al.
Publicado: (2019) -
Freshwater Clam Extract Ameliorates Triglyceride and Cholesterol Metabolism through the Expression of Genes Involved in Hepatic Lipogenesis and Cholesterol Degradation in Rats
por: Laurent, Thomas, et al.
Publicado: (2013)